46843002: Xanthine (substance)

SNOMED CT Concept\Substance\...

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Purine and/or purine derivative\Xanthine and/or xanthine derivative (substance)\Xanthine

\Body substance\Metabolite (substance)\Intermediary product of metabolism\Xanthine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

78078018 Xanthine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

784236011 Xanthine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Xanthine	Is a	Purine or purine derivative	false	Inferred relationship	Some
Xanthine	Is a	Simple physiological organic compound	false	Inferred relationship	Some
Xanthine	Is a	Intermediary product of metabolism	true	Inferred relationship	Some
Xanthine	Is a	Allergen class	false	Inferred relationship	Some
Xanthine	Is a	Vasodilator (substance)	false	Inferred relationship	Some
Xanthine	Is a	Drug allergen	false	Inferred relationship	Some
Xanthine	Is a	Drug pseudoallergen by function	false	Inferred relationship	Some
Xanthine	Is a	Drug allergen	false	Inferred relationship	Some
Xanthine	Is a	Xanthine or xanthine derivative	false	Inferred relationship	Some
Xanthine	Is a	Xanthine and/or xanthine derivative (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Theophylline 300mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Theophylline 50mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Theophylline, anhydrous 600mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing diprophylline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aspirin + caffeine + orphenadrine citrate tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing caffeine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Caffeine-containing product in rectal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing caffeine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline-containing product in rectal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline 250 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline 105mg/5ml oral liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing diprophylline in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Diprophylline-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Dyphylline + guaifenesin 300mg/300mg liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Theophylline m/r	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Theophylline-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing caffeine and ergotamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing aspirin and butalbital and caffeine and codeine phosphate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing ephedrine and theophylline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing caffeine and isometheptene mucate and paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing diprophylline and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing aspirin and caffeine and propoxyphene hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing potassium iodide and theophylline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing aspirin and caffeine and dihydrocodeine tartrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing caffeine and sodium benzoate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing butalbital and caffeine and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing ephedrine sulfate and hydroxyzine hydrochloride and theophylline	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aspirin + caffeine + orphenadrine citrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing butalbital and caffeine and codeine phosphate and paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing guaifenesin and theophylline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Product containing aspirin and butalbital and caffeine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline hydrate 350mg modified-release tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline hydrate 225mg modified-release tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Aminophylline hydrate 100mg modified-release tablets	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xanthine	Inferred relationship	Some
Urine xanthine level (procedure)	Component	False	Xanthine	Inferred relationship	Some	2
Pamabrom	Is a	False	Xanthine	Inferred relationship	Some
Allergy to xanthine	Causative agent (attribute)	True	Xanthine	Inferred relationship	Some	1
Xanthine overdose	Causative agent (attribute)	True	Xanthine	Inferred relationship	Some	1
Xanthine adverse reaction	Causative agent (attribute)	True	Xanthine	Inferred relationship	Some	1
Urine xanthine level (procedure)	Component	True	Xanthine	Inferred relationship	Some	1

Start Previous Page 3 of 3

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
78078018	Xanthine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
784236011	Xanthine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core